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ABSTRACT:M 1dG (3-(2′-deoxy- -D-erythro-pentofuranosyl)pyrimido[1,2-a]purin-10(3H)-one) lesions are
mutagenic in bacterial and mammalian cells, leading to base substitutions (mostly M1dG to dT and M1dG
to dA) and frameshift mutations. M1dG is produced endogenously through the reaction of peroxidation
products, base propenal or malondialdehyde, with deoxyguanosine residues in DNA. The mutagenicity
of M1dG in Escherichia coli is dependent on the SOS response, speciﬁcally the umuC and umuD gene
products, suggesting that mutagenic lesion bypass occurs by the action of translesion DNA polymerases,
like DNA polymerase V. Bypass of DNA lesions by translesion DNA polymerases is conserved in bacteria,
yeast, and mammalian cells. The ability of recombinant human DNA polymerase η to synthesize DNA
across from M1dG was studied. M1dG partially blocked DNA synthesis by polymerase η. Using steady-
state kinetics, we found that insertion of dCTP was the least favored insertion product opposite the M1dG
lesion (800-fold less efﬁcient than opposite dG). Extension from M1dG·dC was equally as efﬁcient as
from control primer-templates (dG·dC). dATP insertion opposite M1dG was the most favored insertion
product (8-fold less efﬁcient than opposite dG), but extension from M1dG·dA was 20-fold less efﬁcient
than dG·dC. The sequences of full-length human DNA polymerase η bypass products of M1dG were
determined by LC-ESI/MS/MS. Bypass products contained incorporation of dA (52%) or dC (16%) opposite
M1dG or -1 frameshifts at the lesion site (31%). Human DNA polymerase η bypass may lead to M1dG
to dT and frameshift but likely not M1dG to dA mutations during DNA replication.
Oxidation of biological macromolecules generates reac-
tive electrophiles that chemically modify DNA. Adducts
resulting from the reaction of DNA with endogenously
produced electrophiles, like malondialdehyde (MDA)
1 and
base propenals, may play a role in mutagenesis and
carcinogenesis. MDA is produced endogenously as a
byproduct of lipid peroxidation and prostaglandin bio-
synthesis and reacts with deoxyguanosine (dG), deoxy-
adenosine (dA), and deoxycytidine (dC) in DNA at
physiological pH (1-5). Reaction with dG results from
the addition of MDA to N2 and N1 to form M1dG (3-(2′-
deoxy- -D-erythro-pentofuranosyl)pyrimido[1,2-a]purin-
10(3H)-one, Figure 1). Whereas formation of M1dG is the
major product of MDA reaction with DNA, reactions with
dA and dC occur at lower levels than with dG, and adduction
occurs at the exocyclic nitrogen without cyclization. The
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FIGURE 1: Formation and structure of M1dG.
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Published on Web 12/24/2008major endogenous source for M1dG formation is likely
through the reaction of dG with base propenals generated
during DNA oxidation (6-8). As structural analogues of
MDA, base propenals produced by agents such as bleomycin
and peroxynitrite are more highly reactive under physiologic
conditions to electrophilic DNA addition than MDA and are
more mutagenic (6, 7).
M1dG is a mutagenic DNA lesion in bacterial and
mammalian cell culture studies (9-14), and M1dG has been
detected in DNA isolated from normal rat and human
liver (15, 16). The proﬁle of the in Vitro chemical reactivity
of MDA with DNA parallels the mutations observed when
single-stranded M13 phage DNA is randomly modiﬁed with
MDA and replicated in Escherichia coli (3-5, 11). The
majority of observed mutations were base pair substitutions
(76% of all mutations, mostly dG to dT with fewer dC to
dT and dA to dG) and frameshift mutations (16% of all
mutations) (11). Site-speciﬁc mutagenesis was used to
determine the biological results of bacterial and mammalian
cell replication of DNA containing M1dG at a deﬁned
location in DNA (13). Base pair substitutions (mostly M1dG
to dT and M1dG to dA) were observed in all cases, and
frameshift mutations occurred when M1dG was placed within
CpG repeat sequences. Similar results were obtained with
the M1dG structural analogue, 1,N2-propano-2′-deoxygua-
nosine (PdG) (17).
The biochemical basis for mutations resulting from un-
repaired M1dG in DNA may result from errors in DNA
replication by polymerases. Many DNA lesions stall DNA
replication by high-ﬁdelity DNA polymerases. In E. coli,
stalling of DNA replication induces a set of genes that
function to repair and/or bypass the DNA damage (SOS
response). Both SOS response-inducible DNA polymerase
IV (dinB) and DNA polymerase V (UmuD′2C) are capable
of bypassing DNA lesions (18). M1dG blocks in Vitro DNA
replication by processive polymerases, and M1dG- and PdG-
induced mutations in bacteria are dependent on induction of
the SOS response (11, 17, 19-22). Additionally, base pair
substitution mutations in replicated PdG-containing DNA are
signiﬁcantly reduced in E. coli lacking functional UmuC or
UmuD proteins. These results suggest that the SOS-induced
DNA polymerase V may bypass M1dG and PdG lesions and
contribute to mutagenesis through DNA replication-depend-
ent errors (23).
The general mechanisms of translesion DNA synthesis are
conserved between E. coli, yeast, and mammalian cells
(18, 24). Mammalian cells contain at least ﬁve DNA
polymerases that replicate past lesions in DNA (DNA poly-
merases η, ι, κ,  , and Rev1). In addition, DNA polymerase
V and DNA polymerase η may have functional and structural
homology (25). In mammalian cells, a variety of targeted
and untargeted mutations were detected in site-speciﬁc
mutagenesis studies using M1dG, suggesting that error-prone
DNA replication may also signiﬁcantly contribute to mu-
tagenesis in mammalian cells (13). Both yeast and human
DNA polymerase η (pol η) bypass PdG and acrolein-
adducted deoxyguanosine in Vitro (26, 27). However, it is
not known whether mammalian translesion DNA poly-
merases bypass M1dG lesions in Vitro and whether lesion
bypass may lead to base pair substitutions or frameshift
mutations during DNA replication. To address this possibil-
ity, we examined the capacity for human DNA polymerase
η to synthesize DNA across from an M1dG lesion placed in
an oligodeoxynucleotide.
MATERIALS AND METHODS
Materials. Recombinant human DNA polymerase η (En-
zymax, Lexington, KY) was aliquoted into 5 µL portions
and stored at -80 °C. T4 polynucleotide kinase and E. coli
uracil DNA glycosylase were obtained from New England
Biolabs (Beverly, MA). [γ-32P]ATP was purchased from
Perkin-Elmer. PAGE-urea gel reagents were purchased from
National Diagnostics, Inc. (Atlanta, GA).
Oligonucleotide Synthesis. The modiﬁed oligonucleotides
was synthesized by a postsynthetic modiﬁcation strategy as
described previously and puriﬁed by HPLC (28). The
oligonucleotide sequence was 5′-TCA CXG AAT CCT TAC
GAG CCC CC-3′, where X ) dG or M1dG. The theoretical
MALDI-TOF MS (HPA) m/z for the (M - H) ion of the
oligonucleotide was 6977.1 and was experimentally deter-
mined to be 6976.9.
Generation of Primer-Template DNA for in Vitro Experi-
ments. The 18-base primer oligonucleotides, 5′-GG GGG
CTC GTA AGG ATT C-3′, were 5′-phosphorylated with T4
polynucleotide kinase with 250 µCi of [γ-32P]ATP (>6000
Ci/mmol) in the presence of 50 mM MOPS, pH 7.5, 10 mM
MgCl2,a n d5m MD T Tf o r1ha t3 7°C. The 32P-labeled
primers were mixed with M1dG-containing or control
template in a 1:1 molar ratio in the presence of 40 mM NaCl
and heated to 95 °C for 2 min, followed by slow cooling
overnight.
Steady-State Kinetics. Human pol η stocks were diluted
in reaction buffer containing 50 mM MOPS, pH 7.5, 5 mM
DTT, 0.01 mg/mL BSA, and 10% glycerol (v/v). Typical
reaction volumes of 10 µL contained 50 nM annealed, 5′-
end-labeled primer-template, 1.6 nM human pol η,5m M
MgCl2, and 1 nM to 1 mM individual nucleoside triphos-
phates in reaction buffer. Enzyme, buffer, and DNA template
were preincubated at 37 °C for 5 min prior to the addition
of MgCl2 and dNTP to initiate the reaction. The reaction
incubation periods were optimized to ensure that the data
collected represented initial velocities of the reactions.
Reactions were terminated by the addition of 10 µLo f9 5 %
formamide, 10 mM EDTA, 0.03% bromophenol blue (w/
v), and 0.03% xylene cylanol (w/v). Reactions were then
heated to 95 °C for 2 min to ensure reaction quenching.
Products were visualized on 20% polyacrylamide-urea gels
by electrophoresis at a constant voltage (3000 V) for 3 h.
Gels were exposed to phosphorimager analysis and quantiﬁed
using the Bio-Rad Image Quant software. Data represent the
mean and standard deviation of three experiments.
Primer Extension Analysis. Reactions were conducted in
reaction buffer with 5 mM MgCl2, 50 nM template, and
varying amounts of human pol η enzyme for 30 min.
Products were visualized on 20% polyacrylamide-urea gels
followed by phosphorimager quantitation.
LC-ESI/MS/MS Analysis of Oligonucleotide Products from
Human DNA Polymerase η. Templates were primed with
the sequence 5′-GG GGG CTC GTA AGG ATU C-3′ for
use in LC-ESI/MS/MS analysis (29). Human pol η (160 nM)
was incubated with 1 nmol (10 µM) of annealed primer-
template for4ha t3 7°C in the presence of 5 mM MgCl2,
dNTPs (1 mM each), 50 mM MOPS, pH 7.5, 5 mM DTT,
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terminated by extraction of unused dNTPs by size exclusion
on a Sephadex G-25 column. Concentrated buffer was added
to restore the buffer concentrations to 20 mM Tris-HCl, pH
8.0, 1 mM DTT, and 1 mM EDTA. The reactions were
initiated by the addition of 20 units of uracil DNA glyco-
sylase and were incubated at 37 °Cf o r6ht ohydrolyze the
uracil residue on the extended primer. The reaction mixture
was then incubated at 95 °Cf o r1hi nt h epresence of 0.25
M piperidine. Solvents were removed by vacuum centrifuga-
tion, and the reaction mixture was resuspended in 100 µL
of H2O for LC-ESI/MS/MS analysis.
LC-ESI/MS/MS analysis was conducted on a Waters
Acquity ultraperformance liquid chromatography system
connected to a Finnigan LTQ mass spectrometer (Thermo-
Electron Corp., San Jose, CA). Negative ion electrospray
ionization was used with a source voltage of 4 kV, source
current 100 µA, auxiliary gas ﬂow rate setting 20, sweep
gas ﬂow rate setting 5, sheath gas ﬂow setting 34, and
capillary voltage -90 V. Buffer A contained 10 mM
NH4CH3CO2 plus 2% CH3CN, and buffer B contained 10
mM NH4CH3CO plus 95% CH3CN. Using a ﬂow rate of
150 µL/min and an Acquity ultraperformace liquid chroma-
tography BEH octadecysilane (C18) column (1.7 µm, 1.0 ×
100 mm) this buffer gradient program was used: 0-3 min,
linear gradient from 100% A to 97% A; 3-4 min, linear
gradient to 80% A; 4-5 min, linear gradient to 0% A (100%
B); 5-5.5 min, hold at 100% B; 5.5-6.5 min, linear gradient
to 100% A; 6.5-9.5 min, hold at 100% A. The column
temperature was maintained at 50 °C. For MS/MS analysis
the normalized collision energy was 35%, activation Q 0.250,
and activation time 30 ms. Nucleotide composition and CID
fragmentations of oligonucleotide sequences were calculated
using the Oligo composition calculator (v1.2) and the Mongo
Oligo mass calculator (v.2.06), respectively, maintained by
the Department of Medicinal Chemistry at the University of
Utah (www.medlib.med.utah.edu/massspec).
RESULTS
Human DNA Polymerase η Replicates DNA Past the
M1dG Lesion. Primer extension studies were conducted to
examine the ability of pol η to synthesize DNA across from
M1dG. M1dG was speciﬁcally incorporated into the ﬁfth
position from the 5′-end of a 24 base pair oligonucleotide
(Figure 2). Unmodiﬁed (control) templates or M1dG-contain-
ing templates were annealed to 18-base standing start (-1)
primers for use in primer extension assays. Template-primer
(50 nM) was incubated with increasing concentrations of pol
η at 37 °C for 30 min in the presence of all four
deoxynucleoside triphosphates (dNTPs) (100 µM). Figure 2
illustrates the extent to which DNA synthesis occurred
opposite and past the M1dG lesion. At the highest enzyme
concentrations used (32 nM) 72% of control templates were
extended to full-length product. The M1dG lesion blocked
incorporation of the initial nucleotide opposite the lesion,
but 14% of templates were extended to full-length product.
DNA replication past M1dG appeared distributive, because
the intensities of bands corresponding to subsequent base
addition were approximately equal.
Steady-State Kinetic Analysis of Nucleotide Incorporation
Opposite M1dG Lesions in DNA. Control or M1dG-containing
primer-template was incubated with catalytic amounts of pol
η and varied concentrations of a single dNTP for various
amounts of time. The amount of one-nucleotide-extended
primer was quantiﬁed to determine the initial velocity of the
enzymatic reaction. Initial velocities were plotted against the
concentration of dNTP used, and nonlinear curve ﬁt regres-
sion analysis was performed to a one-site hyperbolic curve
(Figure 3). From this analysis Km and kcat values were
determined (Table 1). Km and kcat values determined from
analysis of the insertion of dCTP opposite dG template by
pol η (Figure 3B) correlated with published data (30).
Incorporation of dCTP opposite M1dG was less favored, with
a 126-fold higher Km and a 7-fold lower kcat than incorpora-
tion of dCTP opposite dG. Incorporation of dATP was
equally as effective opposite M1dG and dG (Figure 3C), as
the kcat and Km values were approximately equal. In contrast
to the incorporation of dATP opposite M1dG or dG, both
the Km and kcat were different for incorporation of dTTP and
dGTP opposite to M1dG or dG (Figure 3D,E). The kcat for
incorporation of dTTP opposite M1dG was 73% lower than
the kcat for incorporation of dTTP opposite dG, and the Km
was approximately one-third of that for incorporation of
dTTP opposite dG. Incorporation of dGTP opposite dG
occurred with 2-fold higher Km and 50% faster kcat than
incorporation opposite M1dG.
Misincorporation frequencies were calculated as the ratio
of kcat/Km for the incorporated nucleotide (control or M1dG
templates) to the ratio of kcat/Km for incorporation of dCTP
opposite dG (Table 1) (31). This analysis determined that
incorporation of dATP opposite the M1dG lesion is most
favored, followed by approximately equivalent efﬁcacy of
incorporation of dGTP and dTTP. Incorporation of dCTP
opposite M1dG was the least kinetically favored insertion
product.
Analysis of Product Extension by Steady-State Kinetics.
Replication of modiﬁed DNA requires both incorporation
of a nucleotide opposite the lesion and extension of the
resulting insertion product. DNA lesions and mispairs may
alter the efﬁciency of extension of bypassed DNA lesions
FIGURE 2: Human DNA polymerase η synthesizes DNA across from
M1dG lesions and forms fully extended DNA products. Primer
extension assays were conducted using decreasing concentrations
of human DNA polymerase η incubated for 30 min with 50 nM
DNA primer-template. Primer-template extension is shown under
conditions with no enzyme (P, primer), unmodiﬁed primer-template
(control, X )dG), and M1dG-modiﬁed primer-template (M1dG, X
) M1dG). Samples were visualized by electrophoresis on a 20%
urea-denatured PAGE.
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matched DNA (32, 33). To determine if pol η extends M1dG-
modiﬁed primer-templates with altered efﬁcacy, primers
terminating with dC or dA were annealed to templates
containing control (dG) or lesion (M1dG). The efﬁcacy of
extension from these templates was measured by determining
the kinetic parameters for incorporation of the next correct
nucleotide (dG) to each primer-template combination (Figure
4). Extension of M1dG·dC pairs occurred with reduced kcat
and Km when compared to the extension of dG·dC pairs.
However, the reduction in kcat balanced the reduction in Km,
and the overall efﬁciency of extension for dG·dC and
M1dG·dC pairs was nearly equivalent (Table 2). By contrast
to the extension of dG·dC and M1dG·dC pairs, the extension
of both dG·dA and M1dG·dA mispairs proceeded with
greatly reduced kcat values, resulting in 50- and 20-fold
reduced efﬁciency of extension, respectively (Table 2). These
results suggest that pol η may extend “correctly” bypassed
M1dG lesions (M1dG·dC) more efﬁciently than “mutageni-
cally” bypassed lesions (M1dG·dA) and equally as well as
extension from undamaged templates. Extension of
M1dG·dG pairs proceeds most efﬁciently when pol η inserts
dTTP opposite the dA residue at the +2 position, which
represents the generation of a -1 frameshift deletion (Table
2). Extension of M1dG·dG pairs by insertion of the next
correct base (dGTP) is less efﬁcient than the event that
corresponds to a -1 frameshift deletion.
LC-ESI/MS/MS Analysis of Full-Length Bypass Products.
To fully characterize the effects of DNA template modiﬁca-
tions on primer extension by pol η, it is necessary to
determine the sequences of full-length DNA products
synthesized by the enzyme in the presence of all four dNTPs.
The products of primer extension from control and M1dG-
modiﬁed template-primers were identiﬁed using an LC-ESI/
MS/MS-based approach. Primer-templates were incubated
at 37 °C with pol η f o r4hi nt h epresence of all four dNTPs
to generate full-length bypass products for sequence deter-
FIGURE 3: Steady-state kinetics for single nucleotide incorporation opposite the M1dG lesion in DNA. (A) Primer-template used for single
nucleotide incorporation studies: X ) dG (control, squares and solid lines) or M1dG (triangles and dashed lines). Primer-template (50 nM)
was incubated with 1.6 nM human DNA polymerase η for various amounts of time in the presence of increasing concentrations of (B)
dCTP, (C) dATP, (D) dGTP, or (E) dTTP. Error bars represent the standard deviation of at least three experiments. Curves were ﬁt to a
single binding site hyperbolic curve.
Table 1: Steady-State Kinetic Parameters for Insertion of Single
Nucleotides Opposite Control and M1dG-Modiﬁed Template by Human
DNA Polymerase η
a
template dNTP Km (µM)
kcat
(s-1 × 103)
kcat/Km
(µM-1 s-1 × 10-3)
f
(misinsertion
frequency)
b
dG C 0.4 ( 0.1 71 ( 1 180 1
A 2.3 ( 0.7 57 ( 2 25 0.13
T4 0 ( 20 48 ( 4 1 0.006
G4 ( 2 5.9 ( 0.4 1.4 0.007
M1dG C 50 ( 20 8.2 ( 0.8 0.2 0.0009
A 2.4 ( 0.8 55 ( 4 23 0.12
T1 4 ( 51 3 ( 1 0.94 0.0050
G3 ( 2 3.9 ( 0.2 1.4 0.007
a Human DNA polymerase η (1.6 nM) was incubated with 50 nM
control (dG) or M1dG-containing templates in the presence of increasing
concentrations of individual dNTPs for various amounts of time. The
initial velocities for the insertion of individual dNTPs were determined
and graphed against the concentration of dNTP to determine kcat and Km
values.
b The frequencies of misincorporation were calculated relative to
insertion of dCTP opposite control (dG) primer-templates as the ratio
(kcat/Km)dNTP/(kcat/Km)dCTP,control.
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3′-end of the primer strand, and reaction products were
digested with uracil DNA glycosylase and hydrolyzed with
piperidine to reduce the products to a size manageable for
LC-ESI/MS/MS sequence analysis.
Two major products were seen for the extension of control
DNA corresponding to ions with m/z of 1086.7 (doubly
charged ion) and 724.2 (triply charged ion) and m/z of 1243.7
(doubly charged ion) and 828.6 (triply charged ion). These
two products corresponded to correct full-length extension
of the primer-template and “blunt-end” addition of dA
following correct full-length extension (Figure S1). The
complete list of theoretical and observed CID fragments for
the two products generated using control DNA as the
template for pol η extension is found in Table S1. Ap-
proximately 69% of the product was extended correctly, and
31% of the product contained the “blunt-end” dA addition
to the full-length product (Figure S1). “Blunt end” addition
of dA to full-length products by pol η has been previously
observed (34).
The substitution of M1dG for dG resulted in four major
products. The major ions observed in the total mass spectrum
resulted from one product with m/z of 1098.7 (doubly
charged ion) and 732.2 (triply charged ion), a second with
m/z of 1087.2 (doubly charged ion) and 724.5 (triply charged
ion), a third with m/z 942.2 (doubly charged ion), and a fourth
with m/z of 836.5 (doubly charged ion) (Figure 5B).
Sequence assignments were made based on CID fragmenta-
tion patterns. The strong signal-to-noise ratio of the CID
spectra indicated that the in Vitro polymerase reaction had
proceeded with good yield. The major product (m/z of 1098.7
and 732.2) corresponded to the incorporation of dA opposite
M1dG (5′-pTCAGTGA-3′, Figure 5C and Table S2). Incor-
poration of dC opposite M1dG (m/z 1087.2 and 732.2, 5′-
pTCCGTGA-3′) was also observed and had a nearly identical
CID fragmentation pattern as observed for the major product
of control reactions (Figure 5D and Table S2). Minor
products were also observed and included incorporation of
dA opposite M1dG with “blunt-end” addition of dA (m/z
836.5, Figure 5F and Table S2) or dG (m/z 1263.2, CID data
not shown). Incorporation of dT or dG opposite M1dG was
not observed.
In addition to incorporation of dA and dC opposite M1dG,
a frameshift product was also observed (m/z 942.2) in which
no nucleotide was incorporated opposite M1dG, but the
enzyme continued to generate a fully extended product. The
DNA sequence of the frameshift product was conﬁrmed by
CID fragmentation in which all of the theoretical a-B and w
ions were observed corresponding to the DNA sequence 5′-
pTC∧GTGA-3′ (Figure 5E and Table S2).
Approximate product ratios for full-length bypass of M1dG
by pol η were determined by integration of the product peak
areas from the selected ion current traces for each of the
four products (Figure 6). Approximately 83% of the total
FIGURE 4: Steady-state kinetics for incorporation of dGTP immediately following the M1dG lesion site. The extension of M1dG·dC or
M1dG·dA paired primer-templates by human DNA polymerase η was analyzed by steady-state kinetics. Increasing concentrations of dGTP
were incubated human DNA polymerase η (1.6 nM) and 50 nM (A) M1dG·dC primer-templates (X ) M1dG, triangles and dashed lines)
or dG·dC primer-templates (X ) dG, squares and solid lines) or (B) M1dG·dA (X ) M1dG, triangles and dashed lines) or dG·dA primer-
templates (X ) dG, squares and solid lines).
Table 2: Steady-State Kinetic Parameters for One-Base Extension of Control and M1dG-Containing Templates by Human DNA Polymerase η
a
template mismatch Km (µM) kcat (s-1 × 10-3) kcat/Km (µM-1 s-1 × 10-3) f (misinsertion frequency)
b
dG dG·dC 0.8 ( 0.3 75 ( 79 0 1
dG·dA 5 ( 2 7.6 ( 0.6 1.4 0.02
dG·dT 1.1 ( 0.2 24 ( 1 22 0.2
dG·dG 3 ( 11 3 ( 1 4 0.04
M1dG M1dG·dC 0.26 ( 0.09 29 ( 2 110 1.2
M1dG·dA 1.2 ( 0.5 5.8 ( 0.6 4.8 0.053
M1dG·dT 10 ( 5 3.5 ( 0.2 0.35 0.0032
M1dG·dG
(dGTP) 3 ( 13 7 ( 1 12.3 0.11
(dTTP) 0.77 ( 0.06 83 ( 2 108 1.2
a Human DNA polymerase η (1.6 nM) was incubated with 50 nM primer-templates pairing dC, dA, dT, or dG with control (dG) or M1dG-containing
templates and varied concentrations of dGTP (or dTTP for the M1dG·dG pair) for 5 min. The initial velocities of incorporation of dNTP (next base
addition) were determined and graphed against the concentration of dGTP to determine kcat and Km values.
b The frequencies of misincorporation were
calculated relative to insertion of dNTP following dC·dG primer-templates as the ratio (kcat/Km)mismatch/(kcat/Km)dG·dC.
Human DNA Polymerase η Bypasses M1dG Biochemistry, Vol. 48, No. 2, 2009 475FIGURE 5: LC-ESI/MS/MS analysis of products from the in Vitro replication of M1dG containing DNA templates by human DNA polymerase
η. (A) Total ion current trace. (B) Total mass spectrum of the mixture of M1dG bypass products. (C) CID spectrum of m/z 1098.7 with
sequence TCAGTGA. (D) CID spectrum of m/z 1087.2 with sequence TCCGTGA. (E) CID spectrum of m/z 942.2 with sequence TC∧GTGA.
(F) CID spectrum of m/z 836.5 with sequence TCAGTGAA. DNA bases shown in bold italic were incorporated opposite M1dG lesions in
the template DNA.
476 Biochemistry, Vol. 48, No. 2, 2009 Stafford et al.products were incorrectly bypassed by pol η. Incorporation
of dA opposite M1dG accounted for 52% of the total products
(including blunt-end addition of dA), and 31% of the bypass
products were -1 frameshifts generated by “skipping” the
lesion site. Insertion of dC opposite M1dG accounted for 16%
of the bypassed product.
DISCUSSION
Our results indicate that the major products of in Vitro
bypass of M1dG by human pol η result from incorporation
of dA opposite M1dG. This substitution would result in an
M1dG to dT transversion upon a second round of DNA
replication (Figure 7) and agrees with published ﬁndings of
in ViVo replication of M1dG containing DNA in nonreiterated
sequences by mammalian and bacterial cells and replication
of MDA-treated DNA in E. coli (11, 13). Insertion of dA
opposite M1dG by human DNA pol η is 130 times more
favorable kinetically than insertion of dC opposite the lesion.
Insertion of dA is also 24-fold more favorable than insertion
of dT and 16-fold more favorable than insertion dG opposite
M1dG.
The sequences of the full-length products of pol η M1dG
lesion bypass in Vitro were determined using LC-ESI/MS/
MS. As suggested by our kinetic data, the major product of
M1dG bypass by pol η is insertion of dA opposite M1dG
(M1dG to dT, Figure 5). In addition, signiﬁcant levels of dC
insertion opposite M1dG were also observed (M1dG to dG,
Figure 5). We quantiﬁed the relative amounts of full-length
products observed in LC-ESI/MS/MS analysis by integration
of the selected ion current trace for individual product ions.
This method assumes that the ionization and detection
efﬁciency of each product is equal. Since the ionization
efﬁciencies of oligonucleotides vary based on sequence, this
method is an approximation of product abundance. A ratio
of 3.3:1 of dA to dC insertion opposite M1dG was observed
in the extension assays characterized by LC-ESI/MS/MS. If
single nucleotide incorporation kinetics alone predicted the
products of M1dG lesion bypass, we would expect a 130:1
ratio of insertion of dA to insertion of dC opposite the lesion
in the full-length products. However, we also observe that
extension from M1dG·dA primer-templates is nearly 24-fold
slower than extension from M1dG·dC primer-templates.
When the kinetics of both insertion and extension are
combined by multiplying the frequencies of misincorporation
for the insertion of dA or dC opposite M1dG (Table 1) with
the frequencies of misincorporation for the extension of
M1dG·dA or M1dG·dC templates (Table 2), we obtain a
predicted ratio of 4.3:1 for the insertion of dA to the insertion
of dC opposite M1dG. This correlates reasonably well with
the observed ratio of full-length products determined by LC-
ESI/MS/MS. Kinetic analysis of the insertion and extension
events predicts that -1 frameshift deletion products should
occur at similar or higher levels than insertion of dA opposite
M1dG, which is slightly different from the higher levels of
dA insertion products observed by LC/MS/MS. Together,
these data reinforce that the sequences of full-length bypass
products are determined by both the efﬁcacy of single
nucleotide insertion and the efﬁciency of bypassed template
extension. Thus, kinetic data obtained from examination of
single nucleotide insertion directly opposite the DNA lesion
may not be uniformly predictive of the actual ratio of
bypassed products observed in the presence of all four
nucleotides.
In addition to base substitution products, pol η bypass of
M1dG generates a product (m/z 942.2) by “skipping” the
M1dG lesion site, which would result in a -1 frameshift after
a second round of replication (Figure 7). This product is
interesting because, unlike many other base modiﬁcations
that result from oxidative stress, M1dG induces frameshift
mutations in ViVo (13, 35). Like other translesion poly-
merases, pol η has an “open” active site, which can
accommodate the presence of two base pairs (36, 37). The
presence of two bases in the active site may allow for the
incoming dGTP to pair with the dC present 5′ to the M1dG
lesion in the template, thus creating a -1 frameshift product.
The involvement of SOS-induced polymerases and Y-family
DNA polymerases in frameshift mutagenesis is documented.
Mutagenicity of benzo[a]pyrene and N-2-acetylaminoﬂuo-
FIGURE 6: Relative abundance of M1dG bypass products. The total
ion current trace is shown with selected ion current traces for the
four major M1dG bypass products indicated. Percentages represent
the relative integrated area of product peaks analyzed in Figure
5C-F. DNA bases in bold italic represent incorporation opposite
the M1dG lesion.
FIGURE 7: Summary of translesion bypass of M1dG by human DNA
polymerase η. The major in Vitro products of human DNA
polymerase η bypass of M1dG lesions in DNA include insertion of
dC or dA opposite the lesion and “skipping” the lesion site. If
subjected to a second round of DNA replication, these bypass
products would lead to correct bypass of the lesion (M1dG to dG),
a G to T transversion (M1dG to dT), or a -1 frameshift mutation.
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by benzo[a]pyrene lesions requires both pol II and pol V
whereas frameshifts are generated uniquely by pol II for
N-2-acetylaminoﬂuorene (38, 39). These results suggest that
DNA replication by translesion DNA polymerases may be
partially accountable for the replication errors that lead to
the observed mutagenicity of M1dG lesions in ViVo. However,
it is noteworthy that full-length bypass products with dT
opposite M1dG were not observed in the present study. Since
M1dG to dA mutations occur at approximately the same
frequency as M1dG to dT, other factors or polymerases may
contribute to the generation of M1dG to dA mutations in
ViVo.
In general, in Vitro replication of adducted primer-
templates by pol η are lesion-speciﬁc and depend on both
the insertion of bases opposite the DNA lesion and the
capacity of the enzyme to synthesize DNA past the bypassed
lesion. For example, pol η preferentially inserts dA-dA
opposite cis-syn cyclobutane pyrimidine dimers and ef-
fectively elongates only primers pairing dA with the dT of
a cis-syn cyclobutane pyrimidine dimer leading to error-free
bypass of the lesion (30, 40-45). Yeast pol η also replicates
past 8-oxoguanine, preferentially inserting dC opposite the
lesion and extending the new template as effectively as
unmodiﬁed DNA (46). Human pol η inserts dC or dT with
approximately equal efﬁcacy opposite O6-methylguanine
(34). Human pol η also replicates past exocyclic deoxygua-
nosine adducts. Increasing the bulk of an alkyl or aromatic
hydrocarbon moiety adducted at the N2-position of dG
reduces the ability of human pol η to replicate through and
past the lesion (47). As adduct bulk increases, the ﬁdelity of
incorporation of dC opposite the adducted dG also decreases,
and extension from the resulting primer-template is con-
comitantly reduced (47). 1,N2-Ethenoguanine adducts are also
bypassed by human pol η. The enzyme inserts dG opposite
the lesion moderately more efﬁciently than dA or dC in single
nucleotide incorporation studies, but only products resulting
from insertion of dG opposite the lesion are fully extended
in LC-ESI/MS/MS analysis (48). This contrasts with the
present results obtained with the close structural analogue,
M1dG.
Studies with the exocyclic acrolein-derived deoxygua-
nosine adduct γ-hydroxy-1,N2-propano-2′-deoxyguanosine
(γ-HOPdG) and its structural analogues suggest that the
kinetics of nucleotide insertion and next base extension by
both yeast and human pol η may be inﬂuenced by ring
opening of the exocyclic adduct (26, 27, 49). Like γ-HOPdG,
M1dG can ring-open to form N2-(3-oxo-1-propenyl)-2′-
deoxyguanosine (50). Ring opening of M1dG is favored
under basic conditions or when placed opposite dC in duplex
DNA (51, 52). Lloyd and co-workers compared the kinetics
of single nucleotide insertion and primer-template extension
by pol η on templates containing γ-HOPdG or ring-closed
(PdG) and ring-opened analogues of γ-HOPdG (26). Inser-
tion of dC by pol η opposite reduced γ-HOPdG (N2-(3-
hydroxypropyl)-2′-deoxyguanosine), which mimics ring-
opened γ-HOPdG, is approximately as efﬁcient as insertion
of dC opposite dG (control), whereas insertion of dC opposite
γ-HOPdG is 100-fold less efﬁcient than control. Similar to
our results with M1dG, insertion of dC opposite PdG is 1600-
fold less efﬁcient than insertion of dC opposite dG (26).
However, in contrast to the extension of M1dG·dC primer-
templates (Figure 3 and Table 2) and reduced γ-HOPdG
containing primer-templates, extension of the ring-closed
PdG·dC primer-templates is signiﬁcantly reduced (140-fold)
compared to dG·dC primer-templates (26). Results similar
to pol η bypass of PdG were obtained with R-hydroxypro-
panodeoxyguanosine, which also exists primarily in a ring-
closed form in duplex DNA (27, 53, 54). It is proposed that
ring opening of the γ-HOPdG lesion may facilitate insertion
of dC opposite the lesion and extension of the dC-inserted
product by permitting Watson-Crick base pairing with the
adducted deoxyguanosine (27). It is not known whether
M1dG exists in the ring-opened or ring-closed state at primer-
template termini or within the active site of pol η. However,
the extremely low efﬁciency of dC insertion opposite M1dG
by pol η but the efﬁcient extension of M1dG·dC-paired
insertion products makes it tempting to speculate that ring
opening of M1dG may follow dC insertion, enabling efﬁcient
extension of the 3-oxopropenyl-dG·dC mispair. It was also
demonstrated that the sequential action of pol ι and pol κ or
yeast Rev1 and pol could catalyze the error-free bypass and
extension of the γ-HOPdG lesion in Vitro (55, 56). It would
be interesting to examine the bypass of the M1dG adduct
with these combinations of translesion polymerases as well.
In summary, we examined replication of M1dG-containing
DNA by recombinant human DNA polymerase η. Multiple
replication bypass products were characterized that result
from alterations in the kinetics of nucleotide insertion
opposite the lesion and extension of lesion-bypassed tem-
plates and frameshifted bypass. Bypass of M1dG lesions by
human DNA polymerase η may lead to the generation of
M1dG to dT and frameshift but likely not M1dG to dA
mutations during DNA replication. These results may be
relevant to the complex mutational proﬁle of M1dG replica-
tion in cells.
At least ﬁve translesion DNA polymerases are present in
mammalian cells, each with unique bypass properties. It is
therefore of biologic interest to determine whether the bypass
of M1dG lesions by alternate human translesion DNA
polymerases leads to base substitutions that generate M1dG
to dA or contribute to M1dG to dT and frameshift mutations
that are observed when M1dG-containing DNA is replicated
in ViVo.
SUPPORTING INFORMATION AVAILABLE
Figures containing control mass spectra and tables con-
taining theoretical and observed CID fragmentation data. This
material is available free of charge via the Internet at http://
pubs.acs.org.
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